AI platform could speed peptide drug discovery | EurekAlert!

Penn Engineers have released PeptiVerse, an open-source AI platform that predicts key chemical and biological properties of peptides—including solubility, cell entry, toxicity, and stability—allowing researchers to filter candidates before expensive synthesis. The tool consolidates fragmented prediction models into a single web interface accessible to biologists without programming expertise, accelerating early-stage drug discovery for peptide therapeutics.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.